The effect of polylactic acid granules on the incidence of alveolar osteitis after mandibular third molar surgery

Effects of the topical hemostatic agent Ankaferd Blood Stopper on the incidence of alveolar osteitis after surgical removal of an impacted mandibular third molar

“…[11,13] These include use of chlorhexidine mouthwash, [22,41,42] the placement of medicated packing into the extraction sockets, [43] the use of different patterns of antibiotics [44][45][46] (systemic antibiotic, topical antibiotic), use of para-hydroxybenzoic acid, [47] and the use of polylactic acid. [37,48,49] Further, for the reliability of outcomes, in this study no other method or technique was used to prevent the formation of AO.…”

Adjunctive effect of a polylactide/polyglycolide copolymer in the treatment of deep periodontal intra‐osseous defects: a randomized clinical trial

“…Although extensively used in orthopaedics (Athanasiou et al 1998), PLA/PGA biomaterials have been scarcely investigated in their cranio‐maxillo‐facial applications. Implantation of PLA‐derived devices was studied to prevent alveolar osteitis or dry socket in extraction sites with contrasting results (Olson et al 1982, Brekke et al 1983, 1986a, b, Hooley & Golden 1995). Meadows et al (1993) compared the treatment of periodontal intra‐osseous defects with access flap alone, PLA implant and decalcified freeze‐dried bone allograft.…”

Local use of antifibrinolytic agent in prevention of alveolar osteitis (A clinical study)

“…The non-pharmacological preventive measures include a comprehensive history of the patient with identification, and if possible, elimination of risk factors associated with an increased risk to develop AO (4) . The pharmacological prophylactic interventions relate to one or more of the following groups antibacterial agents (5) , antiseptic agents (6) , antifibrinolytic agents (7) , steroid anti-inflammatory agents (8) , attending dressings (9) and clot support agents (10) .…”